Status | Study |
Completed |
Study Name: Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy Condition: Progressive Multifocal Leukoencephalopathy Date: 2016-09-06 |
Recruiting |
Study Name: Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells Condition: Leukoencephalopathy Date: 2016-02-27 Interventions: Biological: PyVST Ex vivo gene |
Completed |
Study Name: JC Virus Reactivation in Multiple Sclerosis Condition: Progressive Multifocal Leukoencephalopathy Multiple Sclerosis Date: 2013-11-20 |
Recruiting |
Study Name: Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis Condition: Multiple Sclerosis Date: 2013-11-04 Interventions: Procedure: biological samples and clinical data |
Active, not recruiting |
Study Name: Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide Condition: Multiple Sclerosis Date: 2013-10-22 Interventions: Drug: teriflunomide 14 mg oral teriflunomide daily O |
Recruiting |
Study Name: Natural History Study of Progressive Multifocal Leukoencephalopathy (PML) Condition: Progressive Multifocal Leukoencephalopathy Date: 2012-11-17 |
Terminated |
Study Name: Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy Condition: Progressive Multifocal Leukoencephalopathy Date: 2010-09-16 |
Terminated |
Study Name: Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS) Condition: Immune Reconstitution Inflammatory Syndrome Leukoencephalopathy, Progr Date: 2010-07-29 Interventions: Drug: Methylprednisolone In in |
Active, not recruiting |
Study Name: Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML) Condition: Progressive Multifocal Leukoencephalopathy Date: 2010-05-26 |
Terminated |
Study Name: Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML) Condition: Progressive Multifocal Leukoencephalopathy Date: 2008-09-03 Interventions: Drug: mefloquine 250 mg orally each day for 3 days and then weekly up to 6 months. |